skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structure-based development of a subtype-selective orexin 1 receptor antagonist

Authors:
; ; ; ; ; ; ; ; ; ; ;  [1]
  1. Marburg
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
NIHFOREIGNOTHER
OSTI Identifier:
1671133
Resource Type:
Journal Article
Journal Name:
Proc. Natl. Acad. Sci. USA
Additional Journal Information:
Journal Volume: 117; Journal Issue: (30) ; 07, 2020
Country of Publication:
United States
Language:
ENGLISH

Citation Formats

Hellmann, Jan, Drabek, Matthäus, Yin, Jie, Gunera, Jakub, Pröll, Theresa, Kraus, Frank, Langmead, Christopher J., Hübner, Harald, Weikert, Dorothee, Kolb, Peter, Rosenbaum, Daniel M., Gmeiner, Peter, Nürnberg), UTSMC), and Monash). Structure-based development of a subtype-selective orexin 1 receptor antagonist. United States: N. p., 2020. Web. doi:10.1073/pnas.2002704117.
Hellmann, Jan, Drabek, Matthäus, Yin, Jie, Gunera, Jakub, Pröll, Theresa, Kraus, Frank, Langmead, Christopher J., Hübner, Harald, Weikert, Dorothee, Kolb, Peter, Rosenbaum, Daniel M., Gmeiner, Peter, Nürnberg), UTSMC), & Monash). Structure-based development of a subtype-selective orexin 1 receptor antagonist. United States. doi:10.1073/pnas.2002704117.
Hellmann, Jan, Drabek, Matthäus, Yin, Jie, Gunera, Jakub, Pröll, Theresa, Kraus, Frank, Langmead, Christopher J., Hübner, Harald, Weikert, Dorothee, Kolb, Peter, Rosenbaum, Daniel M., Gmeiner, Peter, Nürnberg), UTSMC), and Monash). Wed . "Structure-based development of a subtype-selective orexin 1 receptor antagonist". United States. doi:10.1073/pnas.2002704117.
@article{osti_1671133,
title = {Structure-based development of a subtype-selective orexin 1 receptor antagonist},
author = {Hellmann, Jan and Drabek, Matthäus and Yin, Jie and Gunera, Jakub and Pröll, Theresa and Kraus, Frank and Langmead, Christopher J. and Hübner, Harald and Weikert, Dorothee and Kolb, Peter and Rosenbaum, Daniel M. and Gmeiner, Peter and Nürnberg) and UTSMC) and Monash)},
abstractNote = {},
doi = {10.1073/pnas.2002704117},
journal = {Proc. Natl. Acad. Sci. USA},
number = (30) ; 07, 2020,
volume = 117,
place = {United States},
year = {2020},
month = {10}
}

Works referenced in this record:

Trends in GPCR drug discovery: new agents, targets and indications
journal, October 2017

  • Hauser, Alexander S.; Attwood, Misty M.; Rask-Andersen, Mathias
  • Nature Reviews Drug Discovery, Vol. 16, Issue 12
  • DOI: 10.1038/nrd.2017.178

Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs
journal, September 2015


The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity
journal, January 1998

  • de Lecea, L.; Kilduff, T. S.; Peyron, C.
  • Proceedings of the National Academy of Sciences, Vol. 95, Issue 1
  • DOI: 10.1073/pnas.95.1.322

Differential expression of orexin receptors 1 and 2 in the rat brain
journal, January 2001

  • Marcus, Jacob N.; Aschkenasi, Carl J.; Lee, Charlotte E.
  • The Journal of Comparative Neurology, Vol. 435, Issue 1
  • DOI: 10.1002/cne.1190

Distribution of orexin receptor mRNA in the rat brain
journal, October 1998


A review of the role of orexin system in pain modulation
journal, June 2017


The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness
journal, February 2007

  • Sakurai, Takeshi
  • Nature Reviews Neuroscience, Vol. 8, Issue 3
  • DOI: 10.1038/nrn2092

The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene
journal, August 1999


Reduced Number of Hypocretin Neurons in Human Narcolepsy
journal, September 2000


Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia
journal, September 2015

  • Roecker, Anthony J.; Cox, Christopher D.; Coleman, Paul J.
  • Journal of Medicinal Chemistry, Vol. 59, Issue 2
  • DOI: 10.1021/acs.jmedchem.5b00832

In Vitro and In Silico Characterization of Lemborexant (E2006), a Novel Dual Orexin Receptor Antagonist
journal, May 2017

  • Beuckmann, Carsten Theodor; Suzuki, Michiyuki; Ueno, Takashi
  • Journal of Pharmacology and Experimental Therapeutics, Vol. 362, Issue 2
  • DOI: 10.1124/jpet.117.241422

Lemborexant: First Approval
journal, February 2020


Current Phase II investigational therapies for insomnia
journal, October 2014


Role of orexin receptors in obesity: from cellular to behavioral evidence
journal, March 2012

  • Perez-Leighton, C. E.; Butterick-Peterson, T. A.; Billington, C. J.
  • International Journal of Obesity, Vol. 37, Issue 2
  • DOI: 10.1038/ijo.2012.30

Discovery and Characterization of ACT-335827, an Orally Available, Brain Penetrant Orexin Receptor Type 1 Selective Antagonist
journal, April 2013

  • Steiner, Michel A.; Gatfield, John; Brisbare-Roch, Catherine
  • ChemMedChem, Vol. 8, Issue 6
  • DOI: 10.1002/cmdc.201300003

Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats
journal, December 2012


A role for lateral hypothalamic orexin neurons in reward seeking
journal, August 2005

  • Harris, Glenda C.; Wimmer, Mathieu; Aston-Jones, Gary
  • Nature, Vol. 437, Issue 7058
  • DOI: 10.1038/nature04071

Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists
journal, November 2018

  • Liu, Hongtao; Hofmann, Josefa; Fish, Inbar
  • Proceedings of the National Academy of Sciences, Vol. 115, Issue 47
  • DOI: 10.1073/pnas.1813988115

D 4 dopamine receptor high-resolution structures enable the discovery of selective agonists
journal, October 2017


Structure-based discovery of opioid analgesics with reduced side effects
journal, August 2016

  • Manglik, Aashish; Lin, Henry; Aryal, Dipendra K.
  • Nature, Vol. 537, Issue 7619
  • DOI: 10.1038/nature19112

Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors
journal, March 2016

  • Yin, Jie; Babaoglu, Kerim; Brautigam, Chad A.
  • Nature Structural & Molecular Biology, Vol. 23, Issue 4
  • DOI: 10.1038/nsmb.3183

Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant
journal, December 2014

  • Yin, Jie; Mobarec, Juan Carlos; Kolb, Peter
  • Nature, Vol. 519, Issue 7542
  • DOI: 10.1038/nature14035

Shaping suvorexant: application of experimental and theoretical methods for driving synthetic designs
journal, January 2014

  • McGaughey, Georgia; Bayly, Christopher I.; Cox, Christopher D.
  • Journal of Computer-Aided Molecular Design, Vol. 28, Issue 1
  • DOI: 10.1007/s10822-014-9710-x

Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis
journal, December 2019


Crystallizing membrane proteins using lipidic mesophases
journal, April 2009


Orexin/hypocretin receptor signalling cascades: Orexin receptor signalling cascades
journal, December 2013

  • Kukkonen, J. P.; Leonard, C. S.
  • British Journal of Pharmacology, Vol. 171, Issue 2
  • DOI: 10.1111/bph.12324

The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases
journal, June 2018


d-myo-Inositol 1-phosphate as a surrogate of d-myo-inositol 1,4,5-tris phosphate to monitor G protein-coupled receptor activation
journal, November 2006


Probing the activation-promoted structural rearrangements in preassembled receptor–G protein complexes
journal, August 2006

  • Galés, Céline; Van Durm, Joost J. J.; Schaak, Stéphane
  • Nature Structural & Molecular Biology, Vol. 13, Issue 9
  • DOI: 10.1038/nsmb1134

Multiplexing of Multicolor Bioluminescence Resonance Energy Transfer
journal, December 2010


Monitoring G protein-coupled receptor and β-arrestin trafficking in live cells using enhanced bystander BRET
journal, July 2016

  • Namkung, Yoon; Le Gouill, Christian; Lukashova, Viktoria
  • Nature Communications, Vol. 7, Issue 1
  • DOI: 10.1038/ncomms12178

Binding kinetics differentiates functional antagonism of orexin-2 receptor ligands: Binding kinetics contrast functional antagonism
journal, December 2013

  • Mould, R.; Brown, J.; Marshall, F. H.
  • British Journal of Pharmacology, Vol. 171, Issue 2
  • DOI: 10.1111/bph.12245

The Use of Physiology-Based Pharmacokinetic and Pharmacodynamic Modeling in the Discovery of the Dual Orexin Receptor Antagonist ACT-541468
journal, June 2017

  • Treiber, Alexander; de Kanter, Ruben; Roch, Catherine
  • Journal of Pharmacology and Experimental Therapeutics, Vol. 362, Issue 3
  • DOI: 10.1124/jpet.117.241596

Determining the Potency and Molecular Mechanism of Action of Insurmountable Antagonists
journal, July 2006

  • Kenakin, Terry; Jenkinson, Stephen; Watson, Christian
  • Journal of Pharmacology and Experimental Therapeutics, Vol. 319, Issue 2
  • DOI: 10.1124/jpet.106.107375

Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold-Hopping Approach
journal, July 2016


Discovery and optimisation of 1-acyl-2-benzylpyrrolidines as potent dual orexin receptor antagonists
journal, January 2015

  • Williams, Jodi T.; Gatfield, John; Roch, Catherine
  • MedChemComm, Vol. 6, Issue 6
  • DOI: 10.1039/C5MD00074B

The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor
journal, September 2015

  • Perrey, David A.; Decker, Ann M.; Li, Jun-Xu
  • Bioorganic & Medicinal Chemistry, Vol. 23, Issue 17
  • DOI: 10.1016/j.bmc.2015.07.013

Label-Free Kinetics: Exploiting Functional Hemi-Equilibrium to Derive Rate Constants for Muscarinic Receptor Antagonists
journal, August 2015

  • Riddy, Darren M.; Valant, Celine; Rueda, Patricia
  • Molecular Pharmacology, Vol. 88, Issue 4
  • DOI: 10.1124/mol.115.100545

Therapeutics development for addiction: Orexin-1 receptor antagonists
journal, March 2020


Selective orexin receptor antagonists
journal, September 2013

  • Lebold, Terry P.; Bonaventure, Pascal; Shireman, Brock T.
  • Bioorganic & Medicinal Chemistry Letters, Vol. 23, Issue 17
  • DOI: 10.1016/j.bmcl.2013.06.057

Binding-Site Compatible Fragment Growing Applied to the Design of β 2 -Adrenergic Receptor Ligands
journal, January 2018


Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database
journal, March 2010

  • Hawkins, Paul C. D.; Skillman, A. Geoffrey; Warren, Gregory L.
  • Journal of Chemical Information and Modeling, Vol. 50, Issue 4
  • DOI: 10.1021/ci100031x

FRED Pose Prediction and Virtual Screening Accuracy
journal, February 2011

  • McGann, Mark
  • Journal of Chemical Information and Modeling, Vol. 51, Issue 3
  • DOI: 10.1021/ci100436p

FRED and HYBRID docking performance on standardized datasets
journal, June 2012